Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Auriemma

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Clinical Endocrinology|December 20, 2008
Significant tumour shrinkage after 12 months of lanreotide Autogel-120 mg treatment given first-line in acromegalyAnnamaria Colao, Renata S Auriemma, Alberto Rebora, et al.
Pituitary|February 23, 2017
Complications of acromegaly: cardiovascular, respiratory and metabolic comorbiditiesRosario Pivonello, Renata S Auriemma, Ludovica F S Grasso, et al.
The International Journal of Artificial Organs|March 4, 2008
The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI)R Bellomo, S Auriemma, A Fabbri, et al.
Clinical Endocrinology|November 9, 2010
Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjectsAnnamaria Colao, Rosario Pivonello, Renata S Auriemma, et al.
European Journal of Endocrinology|February 17, 2010
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawalRenata S Auriemma, Mariano Galdiero, Ludovica F S Grasso, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2006
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patientsAnnamaria Colao, Rosario Pivonello, Renata S Auriemma, et al.
European Journal of Endocrinology|June 1, 2014
Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy)Annamaria Colao, Silvia Vandeva, Rosario Pivonello, et al.
Frontiers in Cellular and Infection Microbiology|July 23, 2021
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman LifeRenata S Auriemma, Roberta Scairati, Guendalina Del Vecchio, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 2008
Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathyAnnamaria Colao, Rosario Pivonello, Maurizio Galderisi, et al.
Journal of Endocrinological Investigation|July 25, 2007
A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patientsA Colao, R Pivonello, L Spinelli, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Clinical Endocrinology|December 20, 2008
Significant tumour shrinkage after 12 months of lanreotide Autogel-120 mg treatment given first-line in acromegalyAnnamaria Colao, Renata S Auriemma, Alberto Rebora, et al.
Pituitary|February 23, 2017
Complications of acromegaly: cardiovascular, respiratory and metabolic comorbiditiesRosario Pivonello, Renata S Auriemma, Ludovica F S Grasso, et al.
The International Journal of Artificial Organs|March 4, 2008
The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI)R Bellomo, S Auriemma, A Fabbri, et al.
Clinical Endocrinology|November 9, 2010
Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjectsAnnamaria Colao, Rosario Pivonello, Renata S Auriemma, et al.
European Journal of Endocrinology|February 17, 2010
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawalRenata S Auriemma, Mariano Galdiero, Ludovica F S Grasso, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2006
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patientsAnnamaria Colao, Rosario Pivonello, Renata S Auriemma, et al.
European Journal of Endocrinology|June 1, 2014
Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy)Annamaria Colao, Silvia Vandeva, Rosario Pivonello, et al.
Frontiers in Cellular and Infection Microbiology|July 23, 2021
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman LifeRenata S Auriemma, Roberta Scairati, Guendalina Del Vecchio, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 2008
Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathyAnnamaria Colao, Rosario Pivonello, Maurizio Galderisi, et al.
Journal of Endocrinological Investigation|July 25, 2007
A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patientsA Colao, R Pivonello, L Spinelli, et al.
Pageof 9